1. Accelerating clinical trial implementation in the context of the COVID-19 pandemic: challenges, lessons learned and recommendations from DisCoVeRy and the EU-SolidAct EU response group. (January 2022) Authors: Diallo, Alpha; Trøseid, Marius; Simensen, Victoria Charlotte; Boston, Anaïs; Demotes, Jacques; Olsen, Inge Christoffer; Chung, Florence; Paiva, José Artur; Hites, Maya; Ader, Florence; Arribas, Jose Ramon; Baratt-Due, Andreas; Melien, Øyvind; Tacconelli, Evelina; Staub, Thèrèse; Greil, Richard; T... Journal: Clinical microbiology and infection Issue: Volume 28:Number 1(2022) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. An open-label randomized controlled trial of the effect of lopinavir/ritonavir, lopinavir/ritonavir plus IFN-β-1a and hydroxychloroquine in hospitalized patients with COVID-19. (December 2021) Authors: Ader, Florence; Peiffer-Smadja, Nathan; Poissy, Julien; Bouscambert-Duchamp, Maude; Belhadi, Drifa; Diallo, Alpha; Delmas, Christelle; Saillard, Juliette; Dechanet, Aline; Mercier, Noémie; Dupont, Axelle; Alfaiate, Toni; Lescure, François-Xavier; Raffi, François; Goehringer, François; Kimmoun, An... Journal: Clinical microbiology and infection Issue: Volume 27:Number 12(2021) Page Start: 1826 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Final results of the DisCoVeRy trial of remdesivir for patients admitted to hospital with COVID-19. Issue 6 (June 2022) Authors: Ader, Florence; Bouscambert-Duchamp, Maude; Hites, Maya; Peiffer-Smadja, Nathan; Mentré, France; Burdet, Charles; Aboab, Jérôme; Ader, Florence; Ait-Oufella, Hafid; Altdorfer, Antoine; Andrejak, Claire; Andreu, Pascal; Argaud, Laurent; Bani-Sadr, Firouzé; Belhadi, Drifa; Belkhir, Leila; Benezit, ... Journal: Lancet infectious diseases Issue: Volume 22:Issue 6(2022) Page Start: 764 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Four-days-a-week antiretroviral maintenance therapy in virologically controlled HIV-1-infected adults: the ANRS 162-4D trial. (25th November 2017) Authors: de Truchis, Pierre; Assoumou, Lambert; Landman, Roland; Mathez, Dominique; Le Dû, Damien; Bellet, Jonathan; Amat, Karine; Katlama, Christine; Gras, Guillaume; Bouchaud, Olivier; Duracinsky, Martin; Abe, Emuri; Alvarez, Jean-Claude; Izopet, Jacques; Saillard, Juliette; Melchior, Jean-Claude; Leibo... Journal: Journal of antimicrobial chemotherapy Issue: Volume 73:Number 3(2018) Page Start: 738 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Low-dose ritonavir-boosted darunavir in virologically suppressed HIV-1-infected adults: an open-label trial (ANRS 165 Darulight). (1st June 2018) Authors: Molina, Jean-Michel; Gallien, Sebastien; Chaix, Marie-Laure; El Abbassi, El Mountacer; Madelaine, Isabelle; Katlama, Christine; Valin, Nadia; Delobel, Pierre; Desseaux, Kristell; Peytavin, Gilles; Saillard, Juliette; Raffi, François; Chevret, Sylvie Journal: Journal of antimicrobial chemotherapy Issue: Volume 73:Number 8(2018) Page Start: 2129 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Once‐daily darunavir/ritonavir 400/100 mg in triple therapy: efficacy and penetration in seminal compartment in ANRS‐165 DARULIGHT study. Issue 1 (12th November 2018) Authors: Lê, Minh P.; Chaix, Marie‐Laure; Raffi, François; Chevret, Sylvie; Gallien, Sébastien; Katlama, Christine; Delobel, Pierre; Yazdanpanah, Yazdan; Saillard, Juliette; Molina, Jean‐Michel; Peytavin, Gilles Journal: British journal of clinical pharmacology Issue: Volume 85:Issue 1(2019) Page Start: 277 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Pharmacokinetic modelling of darunavir/ritonavir dose reduction (800/100 to 400/100 mg once daily) in a darunavir/ritonavir-containing regimen in virologically suppressed HIV-infected patients: ANRS 165 DARULIGHT sub-study. (13th June 2018) Authors: Lê, Minh P; Chaix, Marie-Laure; Chevret, Sylvie; Bertrand, Julie; Raffi, François; Gallien, Sébastien; El Abbassi, El Mountacer Billah; Katlama, Christine; Delobel, Pierre; Yazdanpanah, Yazdan; Saillard, Juliette; Molina, Jean-Michel; Peytavin, Gilles Journal: Journal of antimicrobial chemotherapy Issue: Volume 73:Number 8(2018) Page Start: 2120 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Pharmacological data of a successful 4‐days‐a‐week regimen in HIV antiretroviral therapy (ANRS 162‐4D trial). Issue 4 (5th November 2020) Authors: Abe, Emuri; Assoumou, Lambert; de Truchis, Pierre; Amat, Karine; Gibowski, Séverine; Gras, Guillaume; Bellet, Jonathan; Saillard, Juliette; Katlama, Christine; Costagliola, Dominique; Girard, Pierre‐Marie; Landman, Roland; Alvarez, Jean‐Claude Journal: British journal of clinical pharmacology Issue: Volume 87:Issue 4(2021) Page Start: 1930 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Remdesivir plus standard of care versus standard of care alone for the treatment of patients admitted to hospital with COVID-19 (DisCoVeRy): a phase 3, randomised, controlled, open-label trial. Issue 2 (February 2022) Authors: Ader, Florence; Bouscambert-Duchamp, Maude; Hites, Maya; Peiffer-Smadja, Nathan; Poissy, Julien; Belhadi, Drifa; Diallo, Alpha; Lê, Minh-Patrick; Peytavin, Gilles; Staub, Thérèse; Greil, Richard; Guedj, Jérémie; Paiva, Jose-Artur; Costagliola, Dominique; Yazdanpanah, Yazdan; Burdet, Charles; Ment... Journal: Lancet infectious diseases Issue: Volume 22:Issue 2(2022) Page Start: 209 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗